Gian Paolo Ballari

  • Citations Per Year
Learn More
BACKGROUND Multipoint left ventricular (LV) pacing (MultiPoint Pacing [MPP], St Jude Medical, Sylmar, CA) in a single coronary sinus branch has been introduced as a novel means of cardiac resynchronization therapy (CRT). It is speculated that MPP improves LV function by capturing a larger LV tissue area, resulting in uniform wavefront propagation throughout(More)
A sizable portion of clinically relevant coronary obstructive lesions is constituted by chronic total occlusions (CTOs), and successful revascularisation of CTOs is thus pivotal for patients’ prognosis and symptomatic relief. Unfortunately, the percutaneous approach to CTO is still fraught by a non-negligible risk of failure (ranging from 10% to 30%) [1].(More)
Aims Patients receiving cardiac resynchronization therapy defibrillators (CRT-Ds) are likely to undergo one or more device replacements, mainly for battery depletion. We assessed the economic impact of battery depletion on the overall cost of CRT-D treatment from the perspectives of the healthcare system and the hospital. We also compared devices of(More)
OBJECTIVE One of the drug-eluting stents that have been introduced into clinical practice is the paclitaxel-eluting stent (PES). Several randomised, controlled clinical trials have already been conducted to evaluate the safety and efficacy of this stent, but data regarding clinical practice are still lacking. The aim of this study was to evaluate the safety(More)
AIMS Device replacement at the time of battery depletion of implantable cardioverter-defibrillators (ICDs) may carry a considerable risk of complications and engenders costs for healthcare systems. Therefore, ICD device longevity is extremely important both from a clinical and economic standpoint. Cardiac resynchronization therapy defibrillators (CRT-D)(More)
  • 1